Shareholder agreements almost universally contain transfer restrictions that prohibit selling shares without company consent. A transfer that violates these restrictions may be void under Delaware law, meaning the buyer acquires nothing. The most common restrictions are transfer consent requirements, rights of first refusal, and prohibited-transferee provisions.
Private company equity documents — whether shareholder agreements, investor rights agreements, voting agreements, or stock purchase agreements — contain transfer restrictions as a standard feature. These restrictions exist because private companies have a strong interest in controlling who owns their equity: unauthorized transfers can complicate future financing rounds, trigger SEC reporting thresholds, introduce unwanted investors, and affect the company's cap table dynamics. The most fundamental restriction is the company consent requirement: the shareholder may not transfer shares to any party without the company's prior written approval. This provision is enforceable and gives the company substantial control over the secondary market for its shares. Under Delaware law, a purported transfer that violates these restrictions is void — the buyer does not acquire the shares, regardless of what price was paid or what documents were signed between the parties. This is not a theoretical risk; it is the legal mechanism by which companies like Anthropic and OpenAI have maintained control over their shareholder bases despite significant secondary market interest. Additional restrictions commonly include rights of first refusal (giving the company or investors the opportunity to buy before any third party does), co-sale rights (giving investors the right to participate in any sale alongside the selling shareholder), and transfer prohibitions to defined categories of prohibited transferees such as competitors.
A ROFR gives the company — and sometimes investors — the right to purchase shares at the same price and terms as any third-party offer. The seller must deliver a ROFR notice after finding a buyer; the company then has 30–60 days to exercise or waive. If exercised, the third-party buyer is displaced but the seller still receives payment.
The right of first refusal is the most commonly misunderstood provision in secondary transaction planning. Its mechanics are procedurally straightforward: when a shareholder finds a willing third-party buyer and negotiates price and terms, the shareholder must deliver a written ROFR notice to the company (and, in dual-ROFR structures, to the company's major investors as well) specifying the proposed buyer, price per share, and material transaction terms. The company then has a defined exercise window — typically 30 to 60 days — during which it may elect to purchase the shares on exactly the terms offered by the third party. If the company exercises the ROFR, it purchases the shares at the negotiated price and the third-party buyer has no further claim to the transaction. If the company waives the ROFR, the sale to the third-party buyer may proceed, subject to satisfaction of any remaining consent requirements. In dual-ROFR structures — common in venture-backed companies — the company has a primary right to purchase the full block of shares, and the company's major investors share a secondary right to purchase any portion the company declines to buy. This layered structure can extend the ROFR process to 60–90 days or more. Companies frequently use the ROFR strategically to prevent shareholders from selling to parties the company disfavors — sovereign wealth funds, competitors, activist investors, or parties whose ownership would create complications for future transactions.
Most shareholder agreements require written company consent independent of the ROFR process. Companies can block secondary sales to buyers they disfavor even after waiving ROFR. Securities law compliance (typically Section 4(a)(1) exemption) and cap table management considerations — including the 2,000-shareholder SEC reporting threshold — also apply.
The company consent requirement operates as a separate gate from the ROFR. Even if the company declines to exercise its ROFR and waives its right to purchase the shares, most shareholder agreements independently require that the company consent in writing to the transfer to the proposed buyer. This two-stage structure gives companies a mechanism to block transfers to buyers they disfavor without having to purchase the shares themselves — a meaningful tool for companies that want to control their shareholder base but may not have the cash or inclination to buy back equity on secondary markets. On the securities law side, the secondary sale of private company shares is a securities transaction subject to federal and state securities laws. The most commonly used exemption is Section 4(a)(1) of the Securities Act, which exempts resales by persons who are not issuers, underwriters, or dealers. Secondary platform transactions are typically structured to comply with this exemption, but the company's cooperation in providing representations and transfer agent authorization is often required to complete the mechanics. Cap table management is an additional consideration: companies approaching the 2,000-shareholder threshold that triggers SEC Exchange Act reporting requirements under Section 12(g) may use transfer restrictions to manage their shareholder count, and consent requirements are a tool for that purpose.
Tax results depend on equity type, holding period, and state of residence. Long-term capital gains treatment requires more than one year of holding. ISO holders face AMT considerations. Basis depends heavily on whether an 83(b) election was made. Secondary transactions at prices significantly above the 409A FMV can also affect the company's future option pricing.
The tax analysis for a secondary transaction requires examining several distinct variables. First, holding period: shares held for more than one year are taxed at long-term capital gains rates (currently up to 20% federal plus the 3.8% net investment income tax for high earners); shares held for one year or less are taxed as ordinary income at rates up to 37% federal. Second, equity type: incentive stock options (ISOs) exercised and held may generate alternative minimum tax (AMT) liability even if not sold, and their sale may have different consequences depending on whether it is a qualifying or disqualifying disposition. Non-qualified stock options (NQSOs or NSOs) produce ordinary income at exercise rather than capital gain; the secondary sale of shares acquired by NSO exercise generates capital gain measured from the exercise date and exercise price. Third, basis: for founders who received restricted stock and made an 83(b) election, basis is the fair market value at the time of the election — typically very low for early-stage companies — producing a large capital gain on sale but potentially at favorable long-term rates. Fourth, 409A implications: a secondary sale at a price materially above the current 409A FMV can force the company to commission a new 409A valuation, increasing the exercise prices of future employee option grants — a consequence that makes companies reluctant to approve secondary transactions at significant premiums to the current FMV.
Section 1202 QSBS treatment requires a holding period of more than five years. Selling before five years forfeits the federal capital gains exclusion entirely — there is no partial credit. For founders with significant appreciation, the tax cost of selling early can be millions of dollars. California does not conform to the federal QSBS exclusion, imposing state tax on the full gain regardless of holding period.
Section 1202 of the Internal Revenue Code provides a capital gains exclusion of up to 100% on the sale of Qualified Small Business Stock, subject to a per-taxpayer cap of the greater of $10 million or 10 times the taxpayer's adjusted basis in the stock. To qualify, the stock must be held for more than five years, must have been acquired at original issuance from a domestic C corporation, and the corporation must have met certain active business and gross asset requirements at the time of issuance. For founders who received equity at or near company formation, the QSBS holding period requirement is frequently satisfiable — but it requires actually holding the stock for the full five years. A secondary sale that occurs even one day before the five-year anniversary forfeits the exclusion entirely; there is no prorated benefit for partial holding periods under current law. The economic magnitude of this forfeiture is significant: for a founder holding $10 million in QSBS appreciation, early sale generates approximately $2.38 million or more in federal tax that would have been excludable had they waited. California's non-conformity with Section 1202 — the state imposes full income tax on capital gains regardless of QSBS status — means California residents must also account for the state tax layer, making the total cost of early sale even more substantial. Founders with QSBS-eligible shares should complete a full tax modeling exercise before agreeing to any secondary transaction.
Major secondary platforms include Forge Global, Hiive, and Nasdaq Private Market. Before engaging any platform, sellers should review their shareholder agreement for applicable restrictions, consult the company about its openness to a secondary sale, and complete tax modeling. Transaction documents should address ROFR waiver, company consent, share representations, and cap table update mechanics.
The secondary market for pre-IPO equity has matured significantly, and platforms such as Forge Global, Hiive, and Nasdaq Private Market provide access to institutional buyers who regularly purchase private company shares. These platforms are familiar with the legal mechanics of secondary transactions and can facilitate introductions and structure deals. However, the platforms facilitate transactions — they do not guarantee company consent, ROFR waiver, or tax efficiency, and the seller's obligations under their shareholder agreement remain their own responsibility. The recommended pre-transaction sequence is: (1) review the shareholder agreement and equity plan documents to identify all transfer restrictions, ROFR provisions, and consent requirements; (2) consult with the company's legal team to determine whether the company is open to a secondary sale and, if so, under what terms; (3) engage a tax advisor with startup equity experience to model the full tax picture, including QSBS analysis, holding period, AMT exposure, and state tax; and (4) engage legal counsel to review the purchase agreement, share representations, ROFR waiver documentation, and cap table update mechanics before signing. The purchase agreement in a secondary transaction typically contains representations by the seller about the shares being free and clear of encumbrances, compliance with transfer restrictions, and accuracy of the seller's equity documentation — representations that carry legal liability if incorrect.
Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com.